Chander Parkash Dora

1.5k total citations
29 papers, 1.2k citations indexed

About

Chander Parkash Dora is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Chander Parkash Dora has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmaceutical Science, 11 papers in Biomaterials and 9 papers in Molecular Biology. Recurrent topics in Chander Parkash Dora's work include Nanoparticle-Based Drug Delivery (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Drug Solubulity and Delivery Systems (7 papers). Chander Parkash Dora is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), Drug Transport and Resistance Mechanisms (7 papers) and Drug Solubulity and Delivery Systems (7 papers). Chander Parkash Dora collaborates with scholars based in India, United States and United Kingdom. Chander Parkash Dora's co-authors include Sanyog Jain, Varun Kushwah, Sarasija Suresh, Charan Singh, Sameer S. Katiyar, Aakash Deep, Sunil Kumar Jena, Ashok Kumar Datusalia, Ashish Kumar Agrawal and Kaushik Kuche and has published in prestigious journals such as Carbohydrate Polymers, Acta Biomaterialia and International Journal of Pharmaceutics.

In The Last Decade

Chander Parkash Dora

28 papers receiving 1.2k citations

Peers

Countries citing papers authored by Chander Parkash Dora

Since Specialization

Citations

This map shows the geographic impact of Chander Parkash Dora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chander Parkash Dora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chander Parkash Dora more than expected).

Fields of papers citing papers by Chander Parkash Dora

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chander Parkash Dora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chander Parkash Dora. The network helps show where Chander Parkash Dora may publish in the future.

Co-authorship network of co-authors of Chander Parkash Dora

This figure shows the co-authorship network connecting the top 25 collaborators of Chander Parkash Dora. A scholar is included among the top collaborators of Chander Parkash Dora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chander Parkash Dora. Chander Parkash Dora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A review on biomacromolecular ligand-directed nanoparticles: New era in macrophage targeting 2025 ·International Journal of Biological Macromolecules ·Rajan Swami, (unknown), (unknown), (unknown), (unknown), Manoj Garg, Chander Parkash Dora	5
2	Phospholipid Complex-based Topical Gel for Codelivery of Erlotinib and Methotrexate in Psoriasis 2025 ·AAPS PharmSciTech ·Sanyog Jain, Suraj N. Mali, (unknown), Chander Parkash Dora, (unknown)	0
3	Nanomaterials in Dentistry: Current Applications and Future Scope 2022 ·Nanomaterials ·(unknown), Chander Parkash Dora, Rajan Swami, (unknown), Predeepkumar Narayanappa Shiroorkar, Nagaraja Sreeharsha, Syed Mohammed Basheeruddin Asdaq, Md. Khalid Anwer	61
4	Lipid- and TPGS-Based Core–Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential 2022 ·AAPS PharmSciTech ·Sameer S. Katiyar, Ravindra Patil, Rohan Ghadi, Kaushik Kuche, Varun Kushwah, Chander Parkash Dora, Sanyog Jain	5
5	Lipid and Biosurfactant Based Core–Shell-Type Nanocapsules Having High Drug Loading of Paclitaxel for Improved Breast Cancer Therapy 2020 ·ACS Biomaterials Science & Engineering ·Sameer S. Katiyar, Rohan Ghadi, Varun Kushwah, Chander Parkash Dora, Sanyog Jain	17
6	Drug-Phospholipid Complex—a Go Through Strategy for Enhanced Oral Bioavailability 2019 ·AAPS PharmSciTech ·Kaushik Kuche, (unknown), Chander Parkash Dora, Sanyog Jain	83
7	Design and Toxicity Evaluation of Novel Fatty Acid-Amino Acid-Based Biocompatible Surfactants 2019 ·AAPS PharmSciTech ·Sameer S. Katiyar, Varun Kushwah, Chander Parkash Dora, Ravindra Patil, Sanyog Jain	20
8	Lipid and TPGS based novel core-shell type nanocapsular sustained release system of methotrexate for intravenous application 2018 ·Colloids and Surfaces B Biointerfaces ·Sameer S. Katiyar, Varun Kushwah, Chander Parkash Dora, Sanyog Jain	10
9	Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate 2018 ·International Journal of Pharmaceutics ·Sameer S. Katiyar, Varun Kushwah, Chander Parkash Dora, Sanyog Jain	8
10	Improved oral bioavailability and therapeutic efficacy of erlotinib through molecular complexation with phospholipid 2017 ·International Journal of Pharmaceutics ·Chander Parkash Dora, Varun Kushwah, Sameer S. Katiyar, Pradeep Kumar, Viness Pillay, Sarasija Suresh, Sanyog Jain	47
11	Formulation, optimization, and in vitro–in vivo evaluation of olmesartan medoxomil nanocrystals 2017 ·Drug Delivery and Translational Research ·Sanyog Jain, Kamlesh D. Patel, Sumit Arora, (unknown), Chander Parkash Dora	19
12	Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment 2017 ·Pharmaceutical Research ·Varun Kushwah, Ashish Kumar Agrawal, Chander Parkash Dora, David J. Mallinson, Dimitrios A. Lamprou, Ramesh C. Gupta, Sanyog Jain	45
13	Improved metabolic stability and therapeutic efficacy of a novel molecular gemcitabine phospholipid complex 2017 ·International Journal of Pharmaceutics ·Chander Parkash Dora, Varun Kushwah, Sameer S. Katiyar, Pradeep Kumar, Viness Pillay, Sarasija Suresh, Sanyog Jain	46
14	Nanostructured lipid carriers of olmesartan medoxomil with enhanced oral bioavailability 2017 ·Colloids and Surfaces B Biointerfaces ·(unknown), Chander Parkash Dora, Varun Kushwah, Sanyog Jain	69
15	Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico , in vitro and in vivo evaluation 2015 ·Carbohydrate Polymers ·(unknown), Chander Parkash Dora, Charan Singh, (unknown), (unknown), M. Elizabeth Sobhia, Sarasija Suresh	88
16	Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability 2015 ·Carbohydrate Polymers ·Chander Parkash Dora, Francesco Trotta, Varun Kushwah, (unknown), Charan Singh, Sarasija Suresh, Sanyog Jain	122
17	A novel nanogel formulation of methotrexate for topical treatment of psoriasis: optimization, in vitro and in vivo evaluation 2015 ·Pharmaceutical Development and Technology ·(unknown), (unknown), Chander Parkash Dora, (unknown), Manjinder Singh Gill, Sarasija Suresh	93
18	Development and evaluation of PEGylated Enoxaparin: A novel approach for enhanced anti-Xa activity 2014 ·Bioorganic Chemistry ·(unknown), Chander Parkash Dora, (unknown), Manjinder Singh Gill, Sarasija Suresh	13
19	Development of tamoxifen-phospholipid complex: Novel approach for improving solubility and bioavailability 2014 ·International Journal of Pharmaceutics ·Sunil Kumar Jena, Charan Singh, Chander Parkash Dora, Sarasija Suresh	99
20	Development and characterization of nanoparticles of glibenclamide by solvent displacement method. 2010 ·PubMed ·Chander Parkash Dora, Shailendra Kumar Singh, Sanjeev Kumar, Ashok Kumar Datusalia, Aakash Deep	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact